選項

處方審核助手

{:__('collect %s',處方審核助手)}

基於臨床指南自動審核處方,識別潛在藥物相互作用與劑量風險,生成標準化審核報告。

提示內容 複製 複製

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all proposed drug names and dosages. Second, based on the latest clinical guidelines and package inserts, check for drug-drug interactions, contraindications, and dosage adjustments for special populations (e.g., hepatic or renal impairment). Finally, if any potential risks or inappropriate usage are identified, clearly specify the issues and provide evidence-based optimization suggestions or alternative regimens, ensuring the output is objective, professional, and compliant with medical safety standards.

複製 複製

請作為資深臨床藥師,對提供的患者處方進行合規性審查。首先,提取患者基本資訊、診斷結果及所有擬用藥物名稱與劑量。其次,依據最新臨床用藥指南和藥品說明書,逐一核查藥物間的相互作用、禁忌症及特殊人群(如肝腎功能不全者)的劑量調整建議。最後,若發現潛在風險或用藥不當之處,請明確指出具體問題並提供基於實證醫學的優化建議或替代方案,確保輸出內容客觀、專業且符合醫療安全規範。

複製 複製
評論 (0)
0/300

推薦

處方審核助手
Act as a clinical pharmacist and review the prescribed medication list against the patient's electronic health records, including medical history, allergies, current medications, and lab results. Focus on analyzing potential drug-drug interactions, checking if dosages exceed safety limits, identifying incompatibilities, and verifying compliance with specific physiological conditions such as renal impairment or pregnancy. Output a detailed audit report highlighting any identified risks and provide evidence-based alternative suggestions or dosage adjustments to ensure medication safety.
處方審核助手
Act as a senior clinical pharmacist and review the following prescription data based on the latest clinical medication guidelines: Patient is 65 years old, diagnosed with type 2 diabetes and mild renal impairment (eGFR 45ml/min), currently taking metformin 1000mg bid, glimepiride 2mg qd, and aspirin 100mg qd. Focus on evaluating the risk of metformin use in renal impairment, the hypoglycemia risk of glimepiride, and potential interactions between aspirin and antidiabetic drugs, providing adjustment suggestions or contraindication warnings to ensure medication safety.
處方審核助手
Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to highlight potential risks and provide adjustment suggestions, finally outputting a structured, professional audit report.
術後復健助手
Based on the patient's vital signs, wound healing grade, and pain scores on post-operative day 3, combined with standard orthopedic rehabilitation guidelines, please generate a concise and easy-to-understand recovery progress assessment report. The report should include the current recovery stage judgment, potential risk warnings, and key home care suggestions for the next week. The language should be gentle and professional, avoiding complex medical jargon to ensure patient comprehension and compliance.
處方審核助手
Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all prescribed drug names and dosages. Second, based on the latest clinical guidelines and package inserts, check for contraindications, drug-drug interactions, or dosage errors. Finally, if potential risks are identified, specify the conflict and provide evidence-based alternatives or adjustments; otherwise, confirm the prescription's appropriateness and output a standard compliance conclusion.
處方審核助手
Act as a clinical pharmacist and review the provided physician's prescription against the patient's electronic health records, including medical history, allergies, current medications, and lab results. Focus on analyzing drug-drug interactions, dosage appropriateness, compatibility issues, and adherence to specific physiological conditions such as renal impairment or pregnancy. Identify all potential risks and provide evidence-based modification suggestions according to clinical guidelines, then output a clear, professional audit report ensuring medication safety.
OR